Smith Thornton Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,583
Closed -$226K 138
2024
Q2
$226K Buy
+1,583
New +$226K 0.17% 118